MCL Clinical Trials
1230 trials from ClinicalTrials.gov. Recruiting trials shown first.
Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma or Other B-cell Cancers
UNKNOWNNCT00003163·PHASE2·Medical College of Wisconsin·10 enrolled
filgrastimsargramostimcyclophosphamidemelphalanautologous bone marrow transplantation+2 more
Flavopiridol in Treating Patients With Refractory Cancer
COMPLETEDNCT00019344·PHASE1·National Cancer Institute (NCI)
alvocidib
Oral Combination Chemotherapy in Treating Elderly Patients With Intermediate or High-Grade Non-Hodgkin's Lymphomas
TERMINATEDNCT00003113·PHASE2·Case Comprehensive Cancer Center·6 enrolled
filgrastimcyclophosphamideetoposidelomustineprocarbazine hydrochloride+1 more
Bleomycin in Treating Patients With Non-Hodgkin's Lymphoma
COMPLETEDNCT00003110·PHASE2·Case Comprehensive Cancer Center·5 enrolled
bleomycin sulfate
Radiolabeled Monoclonal Antibody, Combination Chemotherapy, and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Refractory B-Cell Cancer
UNKNOWNNCT00004086·PHASE1·Garden State Cancer Center at the Center for Molecular Medicine and Immunology
filgrastimcisplatincytarabineetoposideifosfamide+4 more
Chemotherapy Given With Amifostine and Filgrastim in Treating Patients With Recurrent or Metastatic Cancer
COMPLETEDNCT00003294·PHASE1·Roswell Park Cancer Institute·24 enrolled
filgrastimamifostine trihydratecarboplatinpaclitaxel
Decitabine in Treating Patients With Melanoma or Other Advanced Cancer
COMPLETEDNCT00002980·PHASE1·California Cancer Consortium
decitabine
High-Dose Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer
COMPLETEDNCT00003116·PHASE2·Case Comprehensive Cancer Center·66 enrolled
filgrastimbusulfancyclophosphamidecyclosporinebone marrow ablation with stem cell support+1 more
Prevention of Graft-Versus-Host Disease in Patients With Advanced Leukemia or Lymphoma Who Are Eligible for Peripheral Stem Cell Transplantation
TERMINATEDNCT00003056·PHASE3·Baxalta now part of Shire·105 enrolled
cyclosporinecyclosporine and methotrexate
Combination Chemotherapy With or Without Idarubicin and Peripheral Stem Cell Transplantation in Treating Patients With Leukemia or Myelodysplastic Syndrome
UNKNOWNNCT00002989·PHASE3·European Organisation for Research and Treatment of Cancer - EORTC·207 enrolled
busulfancyclophosphamideidarubicinmelphalanradiation therapy
Prevention of Graft-Versus-Host Disease in Patients Undergoing Bone Marrow Transplantation
COMPLETEDNCT00003538·NA·Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
graft versus host disease prophylaxis/therapyallogeneic bone marrow transplantation
Radiolabeled Monoclonal Antibody in the Detection and Staging of Patients With Non-Hodgkin's Lymphoma
UNKNOWNNCT00003337·PHASE3·Gilead Sciences·100 enrolled
immunoscintigraphytechnetium Tc 99m epratuzumab
Monoclonal Antibodies in Detecting Residual Disease in Patients Who Have Been Treated for Non-Hodgkin's Lymphoma
UNKNOWNNCT00003338·PHASE2 / PHASE3·Gilead Sciences·60 enrolled
immunoscintigraphytechnetium Tc 99m epratuzumab
Phenylbutyrate in Treating Patients With Refractory Solid Tumors or Lymphoma
COMPLETEDNCT00002909·PHASE1·National Cancer Institute (NCI)·24 enrolled
chemotherapyoral sodium phenylbutyrate
Umbilical Cord Blood and Placental Blood Transplantation in Treating Patients With Hematologic Cancer or Aplastic Anemia
UNKNOWNNCT00008164·PHASE2·Herbert Irving Comprehensive Cancer Center·30 enrolled
umbilical cord blood transplantation
Bryostatin 1 in Treating Patients With Relapsed Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia
COMPLETEDNCT00002908·PHASE2·Barbara Ann Karmanos Cancer Institute
bryostatin 1vincristine sulfate
Immunotherapy for Lymphoproliferative Diseases Associated With Epstein-Barr Virus in Patients Who Have Undergone Organ Transplants
WITHDRAWNNCT00002956·PHASE1·University of Alabama at Birmingham
allogeneic Epstein-Barr virus-specific cytotoxic T lymphocytes
Cladribine in Patients With Mantle Cell Lymphoma
COMPLETEDNCT00002879·PHASE2·Alliance for Clinical Trials in Oncology·51 enrolled
cladribine
Perillyl Alcohol in Treating Patients With Refractory Cancer
COMPLETEDNCT00002862·PHASE1·National Cancer Institute (NCI)·25 enrolled
perillyl alcohol
Bryostatin-1 in Treating Patients With Recurrent Non-Hodgkin's Lymphoma
COMPLETEDNCT00002725·PHASE2·National Cancer Institute (NCI)·35 enrolled
bryostatin 1chemotherapy
Blood Stem Cell Transplant in Treating Patients With Hematologic Cancer
TERMINATEDNCT00008216·Columbia University·48 enrolled
Peripheral Blood Stem Cell Transplantation
Combination Chemotherapy With or Without Biological Therapy in Treating Patients With Refractory Solid Tumor or Lymphoma
COMPLETEDNCT00005021·PHASE1·Fox Chase Cancer Center·17 enrolled
filgrastimcarboplatinpaclitaxeltopotecan hydrochloride
Heparin or Enoxaparin in Patients With Cancer
COMPLETEDNCT00004875·Northwestern University·6 enrolled
enoxaparinheparin
Irinotecan Plus Cyclosporine and Phenobarbital in Treating Patients With Solid Tumors or Lymphoma
COMPLETEDNCT00002759·PHASE1·National Cancer Institute (NCI)·3 enrolled
cyclosporineirinotecan hydrochloridephenobarbital
Bone Marrow Transplantation in Treating Patients With Severe Aplastic Anemia or Rejection of Previous Bone Marrow Transplant
TERMINATEDNCT00005852·PHASE2·H. Lee Moffitt Cancer Center and Research Institute
anti-thymocyte globulinfilgrastimmuromonab-CD3cyclophosphamidecyclosporine+2 more
Immunotoxin in Treating Patients With Leukemia or Lymphoma
COMPLETEDNCT00002765·PHASE1·National Cancer Institute (NCI)
LMB-2 immunotoxin
Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's Lymphoma or Hodgkin's Disease
COMPLETEDNCT00005613·PHASE2·H. Lee Moffitt Cancer Center and Research Institute·147 enrolled
cyclophosphamideetoposideBCNU
Paclitaxel and Estramustine in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
COMPLETEDNCT00021372·PHASE2·Fox Chase Cancer Center·25 enrolled
estramustine phosphate sodiumpaclitaxel
Interferon Alfa-2b Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Refractory Hodgkin's Disease or Non-Hodgkin's Lymphoma
UNKNOWNNCT00003924·PHASE3·Lymphoma Study Association·360 enrolled
recombinant interferon alfa
Immunotherapy in Treating Patients Who Are Undergoing Bone Marrow or Peripheral Stem Cell Transplantation
COMPLETEDNCT00002673·PHASE2·Fred Hutchinson Cancer Center·30 enrolled
infection prophylaxis and management